Skip to main content
Caplight Logo









OncoGenesis, Inc.

OncoGenesis, Inc.

Private
Salinas, CaliforniaHealthcare & Life Scienceshttps://oncogenx.com/

Last Round

VC Round

Jul 1, 2019

Total Funding Raised

$8M

Company Overview

OncoGenesis, Inc. is a medical technology company that develops diagnostic systems and self-collection devices for cervical cancer screening.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service

AI Layer

Non-AI

Keywords

image-guided superficial radiotherapyIG-SRTnon-melanoma skin cancernon-surgical skin cancer treatmentdermatology medical deviceradiation oncologyskin cancer radiotherapynon-invasive cancer therapyGentleCureradiation therapyskin cancer surgery alternativemedical equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoGenesis, Inc. Comparables

Compare OncoGenesis, Inc. with similar companies based on industry and business-model similarity.

OncoGenesis, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aindra Systems
35%
Hera Biotech
35%
Teal Health
34%

OncoGenesis, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 1, 2019
SeedSep 1, 2018

Key People

Founding team and executive leadership

Paul Vichi

Co-Founder, Chief Technology Officer & SVP

Founding Team

OncoGenesis, Inc. Investors

Notable investors and investment history

OncoGenesis, Inc. investors
InvestorRounds
US Capital Global SecuritiesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 75% MoM, reaching 5K.

  • Apr 16, 2026

    Monthly visitors increased 145% MoM, reaching 4.6K.

OncoGenesis, Inc. Filings

Explore SEC and related filing metadata, where available.

OncoGenesis, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OncoGenesis, Inc.'s valuation, stock price, and market status.

Is OncoGenesis, Inc. a public or private company?

OncoGenesis, Inc. is a private company.

What is the current stock price of OncoGenesis, Inc.?

OncoGenesis, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is OncoGenesis, Inc. worth (valuation)?

Valuation information for OncoGenesis, Inc. is not publicly available.

Can I buy OncoGenesis, Inc. stock?

OncoGenesis, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OncoGenesis, Inc.'s last funding round?

OncoGenesis, Inc.'s most recent funding round was VC Round on July 1, 2019.

Who are the main investors in OncoGenesis, Inc.?

Key investors in OncoGenesis, Inc. include US Capital Global Securities.

Will OncoGenesis, Inc. IPO soon?

No public IPO plans have been announced for OncoGenesis, Inc..

How can I track OncoGenesis, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OncoGenesis, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSalinas, California
Employee Range4
Year Founded2008
Last FundingJul 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?